Companies: 10,795·Total market cap: $144.5T
AN2 Therapeutics, Inc.

AN2 Therapeutics, Inc.

ANTXNASDAQHealthcare● Active
$3.85
+$0.03(+0.79%)
Market Cap$105497792
P/E Ratio
52W High$6.91
52W Low$1

AN2 Therapeutics, Inc.(ANTX)股价预测与分析师目标价

华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。

antx · 股价预测 · 8 位分析师(近3月)· FMP · 更新于 2026年6月9日

分析师评级与共识

基于过去 3 个月内 8 位华尔街分析师

SellBuy

Buy

8 位分析师

共识

评级分布

Strong Buy
0
Buy
5
Hold
3
Sell
0
Strong Sell
0
合计: 8 · 买入占比: 62.5%

12 个月目标价

High

$9.00

Consensus

$9.00

+133.8% upside

Low

$9.00

Median: $9 · Last Close: $3.85

AN2 Therapeutics, Inc.(ANTX)的分析师共识为 Buy,基于过去 3 个月内 8 位华尔街分析师的评级。ANTX 的 12 个月平均目标价为 $9.00,相对当前价 $3.85 代表 +133.8% 的潜在上行空间。

12 个月目标价预测

历史收盘价 + 分析师 12 个月目标价预测区间

分析师目标价覆盖不足,无法为该股票生成预测图表。

短期股价预测

算法生成 · 每日更新

DatePredicted PriceChange
2026-06-10$3.665.00%

1-day model range: $3.63–$3.68. Peak: $3.68 (-5.00%).

长期股价预测

⚠️ 在满 252 个交易日历史(IPO/上市时间较短)前不展示长期预测;短期标签页仍可能显示模型输出。

基于技术分析的股价预测

14 项技术面信号(SMA×6 + EMA×6 + RSI + MACD)· EEAT 方法论透明

Market Sentiment

BEARISH

Based on 14 technical indicators

0%36%64%
0Buy
5Neutral
9Sell
RSI (14)32.2Neutral
MACDBEARISH

Refreshes daily from EOD close

Moving Averages · ANTX · Jun 9, 2026

Simple Moving Average (SMA)
MA 5$4.02SELL
MA 10$4.25SELL
MA 20$4.43SELL
MA 50$4.09SELL
MA 100$0.00NEUTRAL
MA 200$0.00NEUTRAL
Current $ANTX · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$4.01SELL
EMA 10$4.18SELL
EMA 20$4.30SELL
EMA 50$4.22SELL
EMA 100$0.00NEUTRAL
EMA 200$0.00NEUTRAL
Current $ANTX · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

最新分析师评级与调整

Filter:
Leerink Partners2026-05-14
Upgrade ↑
Market PerformOutperform
JMP Securities2025-05-05
Maintains
Market OutperformMarket Outperform
Citizens Capital Markets2025-03-26
Maintains
Market OutperformMarket Outperform
Citizens Capital Markets2025-02-25
Maintains
Market OutperformMarket Outperform
JMP Securities2025-02-03
Maintains
Market OutperformMarket Outperform
JMP Securities2024-11-19
Maintains
Market OutperformMarket Outperform
TD Cowen2024-11-18
Downgrade ↓
BuyHold
JMP Securities2024-08-09
Maintains
Market OutperformMarket Outperform
Leerink Partners2024-07-03
Upgrade ↑
Market PerformOutperform
Evercore ISI Group2024-05-16
Maintains
In LineIn Line

Wall Street analysts have recently issued updated ratings on AN2 Therapeutics, Inc. (ANTX) stock. Of the recent 21 rating actions, 3 were upgrades and 5 were downgrades. 8 analysts currently cover ANTX.

分析师推荐趋势

Buy ratings11
Hold ratings00
Sell ratings00

ANTX analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.

财务预测:EPS 与营收一致预期

Revenue This Year

$0M

↓ 100.0% YoY

Revenue Next Year

$33M

EPS This Year

$-1.72

EPS Next Year

$-1.12

↓ 35.0% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast ANTX EPS of $-1.72 for the current fiscal year, based on estimates from 2 analysts. The ANTX revenue forecast is $0M for the current year. These are analyst consensus estimates via FMP / S&P Global.

关于预测与目标价

ANTX 股价预测由两类独立数据源支撑:来自 8 位华尔街分析师(S&P Global / FMP)的共识评级,以及基于历史日终价计算的技术分析。ANTX 的共识目标价为 $9.00(+133.8% 上行空间),分析师共识为 Buy。

ANTX 的短期预测(明日)为 $3.66(-5.00%)。

AN2 Therapeutics, Inc. 在 NASDAQ 上市,代码 ANTX。ANTX 在 2027 年的整体展望偏积极,在覆盖分析师中约 63% 对应 Buy 共识。

常见问题答案综合分析师目标价、一致预期及页面展示的模型结果。

常见问题

ANTX 预测 · 8 个问题

根据 8 位华尔街分析师,ANTX 的 12 个月平均目标价为 $9.00,最高 $9.00、最低 $9.00。若有图表,中位目标价可在上方查看。相对当前价 $3.85,隐含约 +133.8% 的上行空间。

ANTX 目标价ANTX 分析师目标价ANTX 12个月目标价目标价 ANTX

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.